Department of Clinical Veterinary Medicine, Swiss Institute for Equine Medicine (ISME), Vetsuisse Faculty, University of Bern, and Agroscope, Bern, Switzerland.
Veterinary Physiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
J Anim Sci. 2018 Jun 4;96(6):2154-2161. doi: 10.1093/jas/sky074.
The aims of this study were to better characterize the adrenal response to i.v. adrenocorticotropic hormone (ACTH) in horses with and without gastric disease and to validate and simplify the ACTH stimulation test by determining the diagnostic accuracy of six consecutive sampling time points after ACTH administration for equine glandular gastric disease (EGGD) and equine squamous gastric disease (ESGD). Twenty-six endurance and eventing horses without clinical disease [Sport Horse Population (SHP)] and an independent population of 62 horses [General Population (GP)] were grouped by gastroscopic findings (no/mild vs. moderate/severe EGGD, grade 0-1 vs. 2-4 ESGD, respectively) and underwent an ACTH stimulation test. Salivary cortisol (ng/mL) was analyzed before and 30, 60, 90, 120, and 150 min after i.v. injection of 1 µg/kg BW synthetic ACTH1-24. The association between having moderate or severe EGGD or ESGD and the amount of salivary cortisol was analyzed by means of receiver-operating characteristic (ROC) analysis. The following explanatory variables were considered: cortisol values for every time point, the area under the curve (AUC)-including all time points and corrected for the baseline-and the partial areas under the curve AUC0-90 and AUC90-150. Sampling after 60 min had highest association with moderate/severe EGGD. The diagnostic potential of the ACTH test was higher for the SHP [sensitivity 100% (95% CI 54% to 100%), specificity 75% (95% CI 51% to 91%), ROC-AUC 91% (95% CI 69% to 98%), 1-sided P-value < 0.001] than for the GP [sensitivity 75% (95% CI 48% to 93%), specificity 52% (95% CI 37% to 67%), ROC-AUC 68% (95% CI 51% to 79%), 1-sided P-value = 0.0064]. There were, however, no significant associations with ESGD. The superiority of sampling after 60 min suggests that the initial release of cortisol rather than its peak or the AUC are relevant regarding EGGD. Even though the wide confidence intervals and thus the lack of diagnostic accuracy do not presently support clinical use, characterization of the adrenal response to an ACTH stimulus improves the understanding of EGGD pathophysiology and its relation to stress.
本研究的目的是更好地描述患有和不患有胃部疾病的马匹对静脉注射促肾上腺皮质激素(ACTH)的肾上腺反应,并通过确定 ACTH 给药后六个连续采样时间点对马腺胃疾病(EGGD)和马鳞状胃疾病(ESGD)的诊断准确性来验证和简化 ACTH 刺激试验。26 匹无临床疾病的耐力和盛装舞步马[运动马种群(SHP)]和 62 匹马的独立种群[普通人群(GP)]根据胃镜检查结果(无/轻度与中度/重度 EGGD,0-1 级与 2-4 级 ESGD)进行分组,并进行了 ACTH 刺激试验。在静脉注射 1μg/kg BW 合成 ACTH1-24 前和 30、60、90、120 和 150 分钟后分析唾液皮质醇(ng/mL)。通过接收者操作特征(ROC)分析,分析了中度或重度 EGGD 或 ESGD 与唾液皮质醇量之间的关系。考虑了以下解释变量:每个时间点的皮质醇值、包括所有时间点的曲线下面积(AUC)和校正基线的 AUC 以及 AUC0-90 和 AUC90-150 的部分面积。60 分钟后的采样与中度/重度 EGGD 具有最高的相关性。对于 SHP,ACTH 试验的诊断潜力更高[灵敏度 100%(95%CI 54%至 100%),特异性 75%(95%CI 51%至 91%),ROC-AUC 91%(95%CI 69%至 98%),单侧 P 值 <0.001]比 GP [灵敏度 75%(95%CI 48%至 93%),特异性 52%(95%CI 37%至 67%),ROC-AUC 68%(95%CI 51%至 79%),单侧 P 值=0.0064]。然而,与 ESGD 无显著相关性。与 60 分钟后采样相比,皮质醇的初始释放而不是其峰值或 AUC 与 EGGD 相关。尽管广泛的置信区间,因此缺乏诊断准确性目前不支持临床使用,但对 ACTH 刺激的肾上腺反应的特征描述可以提高对 EGGD 病理生理学及其与应激的关系的理解。